Answers are grounded in this paper and cite their sources.
Survival in CLL patients improved in the era of chemoimmunotherapy, and this was largely explained by reduced CLL-related mortality. The increased rate of CLL-related mortality in patients with comorbidities emphasizes the importance of the newer and better tolerated targeted therapy.
No takes yet. Share an insight, caveat, or question.
Steingrímsson et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: